Connect with us

Headlines

Rarebreed Raises $36M to Support Veterinary Care

It plans to triple its number of practices by the end of the year.

mm

Published

on

Rarebreed Veterinary Partners has closed on a $36 million funding round from private investors.

The company plans to put the money toward its “primary goal of practices expansion,” according to a news item on its website. Its business model involves buying a controlling share of veterinary practices and running administrative operations, such as payroll and employee benefits.

Podcast: Marketing Pro Giselle Ugarte on Using LinkedIn to Grow Your Pet Business
Behind the Pages

Podcast: Marketing Pro Giselle Ugarte on Using LinkedIn to Grow Your Pet Business

Podcast: Get Social with Jennifer Kirk of Posh Puppy Boutique and Vanderpump Dog Foundation
Behind the Pages

Podcast: Get Social with Jennifer Kirk of Posh Puppy Boutique and Vanderpump Dog Foundation

Podcast: Should You Carry Poop Bags Featuring the Faces of Donald Trump and Joe Biden?
Behind the Pages

Podcast: Should You Carry Poop Bags Featuring the Faces of Donald Trump and Joe Biden?

The round brings the firm to $42 million in funding since its founding in 2018.

Rarebreed is growing, with plans to triple its number of practices by the end of the year. As of right now, it owns 10 clinics.

Rarebreed hopes to reach 35 practices by the end of 2020, which means it will be looking for 700 more employees. As of right now, Rarebreed has 200 employees at its investment practices, and it employs 15 at its Portland headquarters on Danforth Street.

Advertisement

Rarebreed co-founder and CEO Dan Espinal points out that it is difficult for veterinarians to practice medicine and run business operations daily. Espinol co-founded Rarebreed with Sean Miller, also a former IDEXX employee who is Rarebreed’s chief operating officer, and with Matt Campbell, a local Maine investor. He also was in charge of the development strategy for IDEXX.

Advertisement

FEATURED VIDEO

Sponsored by Cogent Solutions Group

Reduce Your Pet’s Hip & Joint Discomfort with the Most Researched Hyaluronan on the Market

Nearly 60% of dogs and 90% of cats suffer from joint discomfort. Trixsyn joint supplement contains a patented and proven hyaluronic acid molecule for maximum efficacy to promote joint, bone, soft tissue, and cartilage health, keeping your pet feeling comfortable, for longer. Trixsyn is veterinarian recommended, safe and all-natural, and contains research-proven ingredients. Get your paws on the most-researched hyaluronic acid on the market. Learn more at Trixsyn.com.

Promoted Headlines

Most Popular